ALEX NIEBRUGGE: Open Payments
NPI 1083204671 · EFFINGHAM, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 24 payments from 10 companies in 2025. Trend: 2023 $107 · 2024 $281 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $196 |
| ABBVIE INC. | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| SANOFI PASTEUR INC. | 2 | $36 |
| Radius Health, Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| PFIZER INC. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
Products named: Wegovy, VRAYLAR, SHINGRIX, Ozempic, Tymlos, ENFLONSIA, BEXSERO, ELIQUIS.
Industry payments across IL — which companies pay providers there.
